Shalby Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 12, 2025, 12:20 pm

Quick Insight

Shalby Ltd, operating in the Hospitals & Medical Services industry, currently trades at a price of 234 with a market capitalization of 2,530 Cr. The company's financial indicators reveal a P/E ratio, ROE, and ROCE of 0.62%, 6.61%, and 14.01% respectively. With Promoters holding a significant 74.27% stake, FIIs at 5.21%, DIIs at 0.19%, and Public at 19.65%, Shalby boasts stability in ownership. The firm's healthy reserves of 885 Cr and manageable borrowings of 476 Cr indicate a strong financial position. However, a high CCC of 698 days warrants attention to working capital management. Investors may find value in Shalby's current P/BV ratio of 2.15x and ICR of 4.14x, suggesting potential for growth and solvency.

Competitors of Shalby Ltd

All Competitor Stocks of Shalby Ltd

Quarterly Result

Last Updated: August 20, 2025, 3:55 am

Below is a detailed analysis of the quarterly data for Shalby Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 296.43 Cr.. The value appears strong and on an upward trend. It has increased from 264.89 Cr. (Mar 2025) to 296.43 Cr., marking an increase of 31.54 Cr..
• For Expenses, as of Jun 2025, the value is 254.90 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 244.05 Cr. (Mar 2025) to 254.90 Cr., marking an increase of 10.85 Cr..
• For Operating Profit, as of Jun 2025, the value is 41.53 Cr.. The value appears strong and on an upward trend. It has increased from 20.84 Cr. (Mar 2025) to 41.53 Cr., marking an increase of 20.69 Cr..
• For OPM %, as of Jun 2025, the value is 14.01%. The value appears strong and on an upward trend. It has increased from 7.87% (Mar 2025) to 14.01%, marking an increase of 6.14%.
• For Other Income, as of Jun 2025, the value is 7.01 Cr.. The value appears strong and on an upward trend. It has increased from 5.32 Cr. (Mar 2025) to 7.01 Cr., marking an increase of 1.69 Cr..
• For Interest, as of Jun 2025, the value is 9.37 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 10.67 Cr. (Mar 2025) to 9.37 Cr., marking a decrease of 1.30 Cr..
• For Depreciation, as of Jun 2025, the value is 16.52 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 16.23 Cr. (Mar 2025) to 16.52 Cr., marking an increase of 0.29 Cr..
• For Profit before tax, as of Jun 2025, the value is 22.65 Cr.. The value appears strong and on an upward trend. It has increased from -0.74 Cr. (Mar 2025) to 22.65 Cr., marking an increase of 23.39 Cr..
• For Tax %, as of Jun 2025, the value is 66.09%. The value appears to be improving (decreasing) as expected. It has decreased from 1,547.30% (Mar 2025) to 66.09%, marking a decrease of 1,481.21%.
• For Net Profit, as of Jun 2025, the value is 7.68 Cr.. The value appears strong and on an upward trend. It has increased from -12.19 Cr. (Mar 2025) to 7.68 Cr., marking an increase of 19.87 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.83. The value appears strong and on an upward trend. It has increased from -1.02 (Mar 2025) to 0.83, marking an increase of 1.85.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 23, 2025, 2:07 pm

Growth

Last Updated: September 5, 2025, 1:26 pm

Balance Sheet

Last Updated: June 16, 2025, 11:23 am

Below is a detailed analysis of the balance sheet data for Shalby Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 107.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 107.00 Cr..
• For Reserves, as of Mar 2025, the value is 885.00 Cr.. The value appears to be declining and may need further review. It has decreased from 893.00 Cr. (Mar 2024) to 885.00 Cr., marking a decrease of 8.00 Cr..
• For Borrowings, as of Mar 2025, the value is 476.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 378.00 Cr. (Mar 2024) to 476.00 Cr., marking an increase of 98.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 236.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 231.00 Cr. (Mar 2024) to 236.00 Cr., marking an increase of 5.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 1,704.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,609.00 Cr. (Mar 2024) to 1,704.00 Cr., marking an increase of 95.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 969.00 Cr.. The value appears strong and on an upward trend. It has increased from 966.00 Cr. (Mar 2024) to 969.00 Cr., marking an increase of 3.00 Cr..
• For CWIP, as of Mar 2025, the value is 8.00 Cr.. The value appears to be declining and may need further review. It has decreased from 15.00 Cr. (Mar 2024) to 8.00 Cr., marking a decrease of 7.00 Cr..
• For Investments, as of Mar 2025, the value is 95.00 Cr.. The value appears strong and on an upward trend. It has increased from 81.00 Cr. (Mar 2024) to 95.00 Cr., marking an increase of 14.00 Cr..
• For Other Assets, as of Mar 2025, the value is 632.00 Cr.. The value appears strong and on an upward trend. It has increased from 547.00 Cr. (Mar 2024) to 632.00 Cr., marking an increase of 85.00 Cr..
• For Total Assets, as of Mar 2025, the value is 1,704.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,609.00 Cr. (Mar 2024) to 1,704.00 Cr., marking an increase of 95.00 Cr..

Notably, the Reserves (885.00 Cr.) exceed the Borrowings (476.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Shalby Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 0.18. This value is below the healthy minimum of 5. It has decreased from 7.78 (Mar 24) to 0.18, marking a decrease of 7.60.
• For Diluted EPS (Rs.), as of Mar 25, the value is 0.18. This value is below the healthy minimum of 5. It has decreased from 7.77 (Mar 24) to 0.18, marking a decrease of 7.59.
• For Cash EPS (Rs.), as of Mar 25, the value is 6.30. This value is within the healthy range. It has decreased from 12.64 (Mar 24) to 6.30, marking a decrease of 6.34.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 92.31. It has decreased from 93.82 (Mar 24) to 92.31, marking a decrease of 1.51.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 92.31. It has decreased from 93.82 (Mar 24) to 92.31, marking a decrease of 1.51.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 101.12. It has increased from 86.93 (Mar 24) to 101.12, marking an increase of 14.19.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 14.90. This value is within the healthy range. It has decreased from 18.29 (Mar 24) to 14.90, marking a decrease of 3.39.
• For PBIT / Share (Rs.), as of Mar 25, the value is 8.79. This value is within the healthy range. It has decreased from 13.43 (Mar 24) to 8.79, marking a decrease of 4.64.
• For PBT / Share (Rs.), as of Mar 25, the value is 5.18. This value is within the healthy range. It has decreased from 11.93 (Mar 24) to 5.18, marking a decrease of 6.75.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 0.17. This value is below the healthy minimum of 2. It has decreased from 7.77 (Mar 24) to 0.17, marking a decrease of 7.60.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.57. This value is below the healthy minimum of 2. It has decreased from 7.83 (Mar 24) to 0.57, marking a decrease of 7.26.
• For PBDIT Margin (%), as of Mar 25, the value is 14.73. This value is within the healthy range. It has decreased from 21.04 (Mar 24) to 14.73, marking a decrease of 6.31.
• For PBIT Margin (%), as of Mar 25, the value is 8.68. This value is below the healthy minimum of 10. It has decreased from 15.44 (Mar 24) to 8.68, marking a decrease of 6.76.
• For PBT Margin (%), as of Mar 25, the value is 5.12. This value is below the healthy minimum of 10. It has decreased from 13.72 (Mar 24) to 5.12, marking a decrease of 8.60.
• For Net Profit Margin (%), as of Mar 25, the value is 0.17. This value is below the healthy minimum of 5. It has decreased from 8.94 (Mar 24) to 0.17, marking a decrease of 8.77.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 0.57. This value is below the healthy minimum of 8. It has decreased from 9.00 (Mar 24) to 0.57, marking a decrease of 8.43.
• For Return on Networth / Equity (%), as of Mar 25, the value is 0.62. This value is below the healthy minimum of 15. It has decreased from 8.40 (Mar 24) to 0.62, marking a decrease of 7.78.
• For Return on Capital Employeed (%), as of Mar 25, the value is 7.56. This value is below the healthy minimum of 10. It has decreased from 11.22 (Mar 24) to 7.56, marking a decrease of 3.66.
• For Return On Assets (%), as of Mar 25, the value is 0.36. This value is below the healthy minimum of 5. It has decreased from 5.23 (Mar 24) to 0.36, marking a decrease of 4.87.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.13. This value is below the healthy minimum of 0.2. It has decreased from 0.17 (Mar 24) to 0.13, marking a decrease of 0.04.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.43. This value is within the healthy range. It has increased from 0.31 (Mar 24) to 0.43, marking an increase of 0.12.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.65. It has increased from 0.64 (Mar 24) to 0.65, marking an increase of 0.01.
• For Current Ratio (X), as of Mar 25, the value is 1.45. This value is below the healthy minimum of 1.5. It has decreased from 1.71 (Mar 24) to 1.45, marking a decrease of 0.26.
• For Quick Ratio (X), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 1. It has decreased from 0.98 (Mar 24) to 0.74, marking a decrease of 0.24.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.33. This value is below the healthy minimum of 4. It has increased from 0.15 (Mar 24) to 0.33, marking an increase of 0.18.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 15.41 (Mar 24) to 0.00, marking a decrease of 15.41.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 9.50 (Mar 24) to 0.00, marking a decrease of 9.50.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 84.59 (Mar 24) to 0.00, marking a decrease of 84.59.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 90.50 (Mar 24) to 0.00, marking a decrease of 90.50.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 4.14. This value is within the healthy range. It has decreased from 12.25 (Mar 24) to 4.14, marking a decrease of 8.11.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.05. This value is below the healthy minimum of 3. It has decreased from 6.21 (Mar 24) to 1.05, marking a decrease of 5.16.
• For Enterprise Value (Cr.), as of Mar 25, the value is 2,534.67. It has decreased from 2,864.54 (Mar 24) to 2,534.67, marking a decrease of 329.87.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.32. This value is within the healthy range. It has decreased from 3.07 (Mar 24) to 2.32, marking a decrease of 0.75.
• For EV / EBITDA (X), as of Mar 25, the value is 15.76. This value exceeds the healthy maximum of 15. It has increased from 14.58 (Mar 24) to 15.76, marking an increase of 1.18.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.96. This value is within the healthy range. It has decreased from 2.75 (Mar 24) to 1.96, marking a decrease of 0.79.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 84.58 (Mar 24) to 0.00, marking a decrease of 84.58.
• For Price / BV (X), as of Mar 25, the value is 2.15. This value is within the healthy range. It has decreased from 2.57 (Mar 24) to 2.15, marking a decrease of 0.42.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.96. This value is within the healthy range. It has decreased from 2.75 (Mar 24) to 1.96, marking a decrease of 0.79.
• For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 24) to 0.00, marking a decrease of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness